Metabolic changes in plasma and immune cells associated with COVID-19 severity, can predict patient survival
Rate of heart complications low for Aussie COVID-19 patients
6 September 2021Spread of Delta SARS-CoV-2 variant driven by combination of immune escape and increased infectivity
6 September 2021Metabolic changes in plasma and immune cells associated with COVID-19 severity, can predict patient survival
COVID-19 patients have differing immune responses that lead to disease outcomes ranging from asymptomatic SARS-CoV-2 infection to death. After examining the blood samples from nearly 200 COVID-19 patients, researchers have uncovered underlying metabolic changes that regulate how immune cells react to the disease. These changes are associated with disease severity and could be used to predict patient survival. The findings were published in the journal Nature Biotechnology.
